Impact of NOL - Nociception Level Index Intraoperative Monitoring on Perioperative Outcomes in Spine Surgery - a Quality Improvement Pilot

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedasense Biometrics Ltd

About this trial

The objective of this study is to evaluate the clinical impact of the NOL nociception level index monitoring on intraoperative and post operative patient outcomes and institutional metrics when used to guide intraoperative analgesia dosing in patients undergoing spine surgery under general anesthesia when compared to a case controlled retrospective cohort.

Eligibility criteria

Qualifiers

Age > 18 years old.

ASA I-III

Elective spine surgery (laminectomy, spinal fusion, and disc replacement) under general anesthesia.

Opioid tolerant and patients with documented chronic pain may be included

Disqualifiers

• Use of any type of anesthesia other than general anesthesia (neuraxial, epidural analgesia or local regional anesthesia)

Use of intraoperative methadone

Non-sinus heart rate

Pregnancy/lactation

Trial design

Treatments tested in this trial

  • NOL guided intraoperative analgesia

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Medasense Biometrics Ltd

Lead sponsor

Thomas Jefferson Health

Collaborator